反応式
[C:1]([C:4]1[CH:9]=[CH:8][C:7]([N:10]2[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:12][CH2:11]2)=[CH:6][CH:5]=1)(O)=[O:2].Cl.[C:24]1([CH2:30][O:31][NH2:32])[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1.CC(C)N=C=NC(C)C>CN(C1C=CN=CC=1)C.C(Cl)Cl>[C:24]1([CH2:30][O:31][NH:32][C:1]([C:4]2[CH:5]=[CH:6][C:7]([N:10]3[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:21])([CH3:22])[CH3:20])=[O:17])[CH2:12][CH2:11]3)=[CH:8][CH:9]=2)=[O:2])[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 4-(4-carboxyphenyl)-1-piperazinecarboxylic acid, 1-(1,1-dimethylethyl) ester (0.032 mol), O-(phenylmethyl)-hydroxylamine hydrochloride (0.064 mol), DMAP (0.03 mol) in DCM p.a. (250 ml) and TEA (14 ml) was stirred at room temperature. DIC (0.064 mol) was added. The reaction mixture was stirred at room temperature for 8 hours, then washed with water, HCl (0.5N) and water. The separated organic layer was dried (MgSO4), filtered and the solvent was evaporated. The residue was purified by column chromatography over silica gel (eluent: DCM/MeOH 98/2). The desired fractions were collected and the solvent was evaporated, yielding 13.7 g of 4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxylic acid, 1,1-dimethylethyl ester (interm. 4).
後処理
- washwashed with water, HCl (0.5N) and water
- dry with materialThe separated organic layer was dried (MgSO4)
- filtrationfiltered
- customthe solvent was evaporated
- customThe residue was purified by column chromatography over silica gel (eluent: DCM/MeOH 98/2)
- customThe desired fractions were collected
- customthe solvent was evaporated
出典と根拠
- ORDレコード
- ord-02cf36fcf8d04acd86d6f9e6dc0082d1
- 出典データセット
- uspto-grants-2010_04
- 特許番号
- US07704998B2
関連ノート
読み込み中…